|
Valeant Pharmaceuticals International Inc., up $1.38 at $46.31 A Stifel Nicolaus analyst kept his "Buy" rating on the pharmaceutical company citing its plans to buy an oral health products firm. Kohlberg Capital Corp., up 42 cents at $6.71 The investment firm's board increased the company's quarterly dividend by 33 percent, citing the benefit of a recent acquisition. Infinity Pharmaceuticals Inc., down $1.02 at $12.86 The drug developer said it was halting the study of a bone cancer treatment following disappointing results from a mid-stage trial.
Copyright 2012 The Associated
Press. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
News | Sports | Business | Rural Review | Teaching & Learning | Home and Family | Tourism | Obituaries
Community |
Perspectives
|
Law & Courts |
Leisure Time
|
Spiritual Life |
Health & Fitness |
Teen Scene
Calendar
|
Letters to the Editor